Pharmacist and physician insight of vancomycin therapeutic drug-monitoring changes

The updated vancomycin guideline for treatment of serious methicillin-resistant Staphylococcus aureus infections prompted institutions to convert from trough to area-under-the-curve monitoring. The physician perception of the transition, coupled with that of pharmacists, was measured by pre- and pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Gregory, Eric R., Stun, Lucy, Mason, Matt J., Wilson, Nicole M., Hammoud, Kassem A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Concise Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726509/
https://www.ncbi.nlm.nih.gov/pubmed/36483332
http://dx.doi.org/10.1017/ash.2022.282
_version_ 1784844803324772352
author Gregory, Eric R.
Stun, Lucy
Mason, Matt J.
Wilson, Nicole M.
Hammoud, Kassem A.
author_facet Gregory, Eric R.
Stun, Lucy
Mason, Matt J.
Wilson, Nicole M.
Hammoud, Kassem A.
author_sort Gregory, Eric R.
collection PubMed
description The updated vancomycin guideline for treatment of serious methicillin-resistant Staphylococcus aureus infections prompted institutions to convert from trough to area-under-the-curve monitoring. The physician perception of the transition, coupled with that of pharmacists, was measured by pre- and postimplementation surveys. Both groups believed safety would be increased without efficacy changes.
format Online
Article
Text
id pubmed-9726509
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-97265092022-12-07 Pharmacist and physician insight of vancomycin therapeutic drug-monitoring changes Gregory, Eric R. Stun, Lucy Mason, Matt J. Wilson, Nicole M. Hammoud, Kassem A. Antimicrob Steward Healthc Epidemiol Concise Communication The updated vancomycin guideline for treatment of serious methicillin-resistant Staphylococcus aureus infections prompted institutions to convert from trough to area-under-the-curve monitoring. The physician perception of the transition, coupled with that of pharmacists, was measured by pre- and postimplementation surveys. Both groups believed safety would be increased without efficacy changes. Cambridge University Press 2022-09-16 /pmc/articles/PMC9726509/ /pubmed/36483332 http://dx.doi.org/10.1017/ash.2022.282 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
spellingShingle Concise Communication
Gregory, Eric R.
Stun, Lucy
Mason, Matt J.
Wilson, Nicole M.
Hammoud, Kassem A.
Pharmacist and physician insight of vancomycin therapeutic drug-monitoring changes
title Pharmacist and physician insight of vancomycin therapeutic drug-monitoring changes
title_full Pharmacist and physician insight of vancomycin therapeutic drug-monitoring changes
title_fullStr Pharmacist and physician insight of vancomycin therapeutic drug-monitoring changes
title_full_unstemmed Pharmacist and physician insight of vancomycin therapeutic drug-monitoring changes
title_short Pharmacist and physician insight of vancomycin therapeutic drug-monitoring changes
title_sort pharmacist and physician insight of vancomycin therapeutic drug-monitoring changes
topic Concise Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726509/
https://www.ncbi.nlm.nih.gov/pubmed/36483332
http://dx.doi.org/10.1017/ash.2022.282
work_keys_str_mv AT gregoryericr pharmacistandphysicianinsightofvancomycintherapeuticdrugmonitoringchanges
AT stunlucy pharmacistandphysicianinsightofvancomycintherapeuticdrugmonitoringchanges
AT masonmattj pharmacistandphysicianinsightofvancomycintherapeuticdrugmonitoringchanges
AT wilsonnicolem pharmacistandphysicianinsightofvancomycintherapeuticdrugmonitoringchanges
AT hammoudkassema pharmacistandphysicianinsightofvancomycintherapeuticdrugmonitoringchanges

Ejemplares similares